Literature DB >> 31006036

Helicobacter pylori infection and gastrointestinal tract cancer biology: considering a double-edged sword reflection.

Jannis Kountouras1, Michael Doulberis2,3, Apostolis Papaefthymiou2, Stergios A Polyzos4, Maria Touloumtzi2, Vardaka Elisabeth2, Nikolaos Kapetanakis2, Christos Liatsos2, Emmanouel Gavalas2, Panagiotis Katsinelos2.   

Abstract

Entities:  

Keywords:  Bone marrow-derived stem cell; Dysbiosis; Gastrointestinal cancer; Helicobacter pylori; Microbiota

Mesh：

Year:  2019        PMID： 31006036     DOI： 10.1007/s00018-019-03106-4

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN： 1420-682X            Impact factor:   9.261


× No keyword cloud information.
  14 in total

Review 1.  Upper gastrointestinal carcinogenesis: H. pylori and stem cell cross-talk.

Authors:  Ioannis Pilpilidis; Jannis Kountouras; Christos Zavos; Panagiotis Katsinelos
Journal:  J Surg Res       Date:  2010-03-06       Impact factor: 2.192

Review 2.  Microbiome in reflux disorders and esophageal adenocarcinoma.

Authors:  Liying Yang; Noami Chaudhary; Jonathan Baghdadi; Zhiheng Pei
Journal:  Cancer J       Date:  2014 May-Jun       Impact factor: 3.360

3.  Sporadic nonampullary duodenal adenoma/carcinoma is associated with not only colon adenoma/carcinoma but also gastric cancer: association of location of duodenal lesions with comorbid diseases.

Authors:  Daisuke Maruoka; Makoto Arai; Hideaki Ishigami; Kenichiro Okimoto; Keiko Saito; Shoko Minemura; Tomoaki Matsumura; Tomoo Nakagawa; Tatsuro Katsuno; Osamu Yokosuka
Journal:  Scand J Gastroenterol       Date:  2015-01-13       Impact factor: 2.423

4.  Helicobacter pylori-induced epithelial-mesenchymal transition, a potential role of gastric cancer initiation and an emergence of stem cells.

Authors:  Yoon Jin Choi; Nayoung Kim; Hyun Chang; Hye Seung Lee; Seon Mee Park; Ji Hyun Park; Cheol Min Shin; Jung Mogg Kim; Joo Sung Kim; Dong Ho Lee; Hyun Chae Jung
Journal:  Carcinogenesis       Date:  2015-03-16       Impact factor: 4.944

Review 5.  Chemoprevention of gastric cancer by Helicobacter pylori eradication and its underlying mechanism.

Authors:  Nayoung Kim
Journal:  J Gastroenterol Hepatol       Date:  2019-03-27       Impact factor: 4.029

6.  Helicobacter pylori infection and gastric cancer biology: tempering a double-edged sword.

Authors:  Alexios-Fotios A Mentis; Marina Boziki; Nikolaos Grigoriadis; Athanasios G Papavassiliou
Journal:  Cell Mol Life Sci       Date:  2019-02-19       Impact factor: 9.261

Review 7.  New aspects of Helicobacter pylori infection involvement in gastric oncogenesis.

Authors:  Jannis Kountouras; Christos Zavos; Dimitrios Chatzopoulos; Panagiotis Katsinelos
Journal:  J Surg Res       Date:  2007-07-27       Impact factor: 2.192

Review 8.  Potential impact of Helicobacter pylori-related metabolic syndrome on upper and lower gastrointestinal tract oncogenesis.

Authors:  Jannis Kountouras; Stergios A Polyzos; Michael Doulberis; Christos Zeglinas; Fotini Artemaki; Elizabeth Vardaka; Georgia Deretzi; Evaggelia Giartza-Taxidou; Dimitri Tzivras; Efthymia Vlachaki; Evangelos Kazakos; Panagiotis Katsinelos; Christos S Mantzoros
Journal:  Metabolism       Date:  2018-06-21       Impact factor: 8.694

9.  The Effect of Campylobacter concisus on Expression of IL-18, TNF-α and p53 in Barrett's Cell Lines.

Authors:  Behrooz Mozaffari Namin; Mohammad Mehdi Soltan Dallal; Nasser Ebrahimi Daryani
Journal:  Jundishapur J Microbiol       Date:  2015-12-26       Impact factor: 0.747

10.  An obesity-associated gut microbiome reprograms the intestinal epigenome and leads to altered colonic gene expression.

Authors:  Yufeng Qin; John D Roberts; Sara A Grimm; Fred B Lih; Leesa J Deterding; Ruifang Li; Kaliopi Chrysovergis; Paul A Wade
Journal:  Genome Biol       Date:  2018-01-23       Impact factor: 13.583
View more
  1 in total

1.  Active Helicobacter pylori Infection is Independently Associated with Nonalcoholic Steatohepatitis in Morbidly Obese Patients.

Authors:  Michael Doulberis; Simone Srivastava; Stergios A Polyzos; Jannis Kountouras; Apostolis Papaefthymiou; Jolanta Klukowska-Rötzler; Annika Blank; Aristomenis K Exadaktylos; David S Srivastava
Journal:  J Clin Med       Date:  2020-03-30       Impact factor: 4.241
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.